{"id": "article-17526_0", "title": "Androgenetic Alopecia -- Continuing Education Activity", "content": "Androgenetic alopecia is a genetically predetermined disorder due to an excessive response to androgens. This condition affects up to 50 percent of males and females and is characterized by progressive loss of terminal hair of the scalp any time after puberty. It follows a characteristic distribution in both males and females. Hair loss is most prominent in the vertex and frontotemporal regions in males. In women, the frontal hairline is typically spared with diffuse hair loss at the crown and top of the head, with loss often marked by a wider center part. This activity examines when this condition should be considered in differential diagnosis, steps\u00a0for evaluation, and treatment options. This activity highlights the role of the interprofessional team in caring for patients with this condition using different modalities tailored to individual needs and presentations.", "contents": "Androgenetic Alopecia -- Continuing Education Activity. Androgenetic alopecia is a genetically predetermined disorder due to an excessive response to androgens. This condition affects up to 50 percent of males and females and is characterized by progressive loss of terminal hair of the scalp any time after puberty. It follows a characteristic distribution in both males and females. Hair loss is most prominent in the vertex and frontotemporal regions in males. In women, the frontal hairline is typically spared with diffuse hair loss at the crown and top of the head, with loss often marked by a wider center part. This activity examines when this condition should be considered in differential diagnosis, steps\u00a0for evaluation, and treatment options. This activity highlights the role of the interprofessional team in caring for patients with this condition using different modalities tailored to individual needs and presentations."}
{"id": "article-17526_1", "title": "Androgenetic Alopecia -- Continuing Education Activity", "content": "Objectives: Identify the clinical manifestations and patterns of androgenetic alopecia in patients of different genders and ages. Screen for cardiovascular risk factors, hormonal imbalances, and other potential comorbidities associated with androgenetic alopecia. Implement evidence-based treatment strategies based on individual patient characteristics and preferences, including medications, low-level laser therapy, or hair transplantation. Coordinate comprehensive care plans for patients, integrating medical and psychological support to enhance the overall management of androgenetic alopecia. Access free multiple choice questions on this topic.", "contents": "Androgenetic Alopecia -- Continuing Education Activity. Objectives: Identify the clinical manifestations and patterns of androgenetic alopecia in patients of different genders and ages. Screen for cardiovascular risk factors, hormonal imbalances, and other potential comorbidities associated with androgenetic alopecia. Implement evidence-based treatment strategies based on individual patient characteristics and preferences, including medications, low-level laser therapy, or hair transplantation. Coordinate comprehensive care plans for patients, integrating medical and psychological support to enhance the overall management of androgenetic alopecia. Access free multiple choice questions on this topic."}
{"id": "article-17526_2", "title": "Androgenetic Alopecia -- Introduction", "content": "Pattern or androgenetic alopecia is a genetically predetermined disorder due to excessive response to androgens, impacting approximately 50% of males and females. [1] This condition is characterized by progressive loss of terminal hair of the scalp, typically occurring following puberty, with a distinctive pattern in both males and females. In males, hair loss is most prominent in the vertex and frontotemporal regions, whereas females tend to retain their frontal hairline\u00a0while experiencing\u00a0diffuse apical hair\u00a0thinning, causing a\u00a0broader appearance of the anterior part of the hair. [2] [3] [4]", "contents": "Androgenetic Alopecia -- Introduction. Pattern or androgenetic alopecia is a genetically predetermined disorder due to excessive response to androgens, impacting approximately 50% of males and females. [1] This condition is characterized by progressive loss of terminal hair of the scalp, typically occurring following puberty, with a distinctive pattern in both males and females. In males, hair loss is most prominent in the vertex and frontotemporal regions, whereas females tend to retain their frontal hairline\u00a0while experiencing\u00a0diffuse apical hair\u00a0thinning, causing a\u00a0broader appearance of the anterior part of the hair. [2] [3] [4]"}
{"id": "article-17526_3", "title": "Androgenetic Alopecia -- Etiology", "content": "Androgenetic alopecia, as indicated by its name, possesses a distinct genetic predisposition and is\u00a0predominantly due to an excessive response to androgen. [5] [6] This condition is characterized by\u00a0a polygenic\u00a0nature with\u00a0varying penetrance degrees, influenced by\u00a0maternal and paternal genes. A familial predisposition towards androgenetic alopecia exists, with sons\u00a0having 5 to\u00a06 times higher relative risk if their fathers experienced balding.", "contents": "Androgenetic Alopecia -- Etiology. Androgenetic alopecia, as indicated by its name, possesses a distinct genetic predisposition and is\u00a0predominantly due to an excessive response to androgen. [5] [6] This condition is characterized by\u00a0a polygenic\u00a0nature with\u00a0varying penetrance degrees, influenced by\u00a0maternal and paternal genes. A familial predisposition towards androgenetic alopecia exists, with sons\u00a0having 5 to\u00a06 times higher relative risk if their fathers experienced balding."}
{"id": "article-17526_4", "title": "Androgenetic Alopecia -- Etiology", "content": "The onset of pattern alopecia\u00a0is contingent upon androgen receptor activation\u00a0and is typically observed after puberty. Prepubertal castration and\u00a0individuals with androgen insensitivity syndrome do not\u00a0exhibit pattern baldness. Both hormone metabolism and androgen receptors play a key role in developing pattern alopecia. [7]", "contents": "Androgenetic Alopecia -- Etiology. The onset of pattern alopecia\u00a0is contingent upon androgen receptor activation\u00a0and is typically observed after puberty. Prepubertal castration and\u00a0individuals with androgen insensitivity syndrome do not\u00a0exhibit pattern baldness. Both hormone metabolism and androgen receptors play a key role in developing pattern alopecia. [7]"}
{"id": "article-17526_5", "title": "Androgenetic Alopecia -- Epidemiology", "content": "Caucasian\u00a0individuals are most\u00a0notably more affected, followed by Asians and African Americans,\u00a0and subsequently by Native American and Inuit populations. The incidence aligns closely with\u00a0age in Caucasian males,\u00a0as approximately 50% are affected by 50 and approximately 80%\u00a0by age 70. The disorder is quite\u00a0common in females, with\u00a0its incidence showing a notable rise\u00a0after menopause. [8] [9]", "contents": "Androgenetic Alopecia -- Epidemiology. Caucasian\u00a0individuals are most\u00a0notably more affected, followed by Asians and African Americans,\u00a0and subsequently by Native American and Inuit populations. The incidence aligns closely with\u00a0age in Caucasian males,\u00a0as approximately 50% are affected by 50 and approximately 80%\u00a0by age 70. The disorder is quite\u00a0common in females, with\u00a0its incidence showing a notable rise\u00a0after menopause. [8] [9]"}
{"id": "article-17526_6", "title": "Androgenetic Alopecia -- Pathophysiology", "content": "The androgen receptor activation shortens the anagen, or growth phase,\u00a0within the normal hair growth cycle, which instigates follicular miniaturization by progressively\u00a0shortening the\u00a0anagen phase in androgenetic alopecia.\u00a0Consequently, hair follicles become\u00a0thinner and shorter, potentially failing not even to penetrate the epidermal layer. Pathological samples reveal\u00a0a decreased 5:0 ratio of anagen to telogen hair, whereas the\u00a0standard ratio is 12:1. [10] [11]", "contents": "Androgenetic Alopecia -- Pathophysiology. The androgen receptor activation shortens the anagen, or growth phase,\u00a0within the normal hair growth cycle, which instigates follicular miniaturization by progressively\u00a0shortening the\u00a0anagen phase in androgenetic alopecia.\u00a0Consequently, hair follicles become\u00a0thinner and shorter, potentially failing not even to penetrate the epidermal layer. Pathological samples reveal\u00a0a decreased 5:0 ratio of anagen to telogen hair, whereas the\u00a0standard ratio is 12:1. [10] [11]"}
{"id": "article-17526_7", "title": "Androgenetic Alopecia -- Pathophysiology", "content": "Individuals with androgenetic alopecia\u00a0exhibit\u00a0elevated dihydrotestosterone (DHT) production, heightened levels of 5 alpha-reductase, and\u00a0an increased abundance of\u00a0androgen receptors in the areas of the scalp affected by balding. This heightened androgenic milieu in the scalp contributes to the progressive miniaturization of hair follicles, leading to the characteristic pattern of hair thinning and eventual hair loss seen in androgenetic alopecia (see Image. Androgenetic Alopecia in Male).", "contents": "Androgenetic Alopecia -- Pathophysiology. Individuals with androgenetic alopecia\u00a0exhibit\u00a0elevated dihydrotestosterone (DHT) production, heightened levels of 5 alpha-reductase, and\u00a0an increased abundance of\u00a0androgen receptors in the areas of the scalp affected by balding. This heightened androgenic milieu in the scalp contributes to the progressive miniaturization of hair follicles, leading to the characteristic pattern of hair thinning and eventual hair loss seen in androgenetic alopecia (see Image. Androgenetic Alopecia in Male)."}
{"id": "article-17526_8", "title": "Androgenetic Alopecia -- Pathophysiology -- Important\u00a0Background Information", "content": "Two\u00a0primary isoforms of the 5 alpha-reductase enzyme exist. This enzyme converts testosterone to DHT,\u00a0a compound with\u00a0a higher affinity for the androgen receptor.\u00a0The Type 2 isoform of the 5 alpha-reductase enzyme plays a more significant role in androgenetic alopecia.", "contents": "Androgenetic Alopecia -- Pathophysiology -- Important\u00a0Background Information. Two\u00a0primary isoforms of the 5 alpha-reductase enzyme exist. This enzyme converts testosterone to DHT,\u00a0a compound with\u00a0a higher affinity for the androgen receptor.\u00a0The Type 2 isoform of the 5 alpha-reductase enzyme plays a more significant role in androgenetic alopecia."}
{"id": "article-17526_9", "title": "Androgenetic Alopecia -- Pathophysiology -- Important\u00a0Background Information", "content": "The Type\u00a01 isoform of 5 alpha-reductase enzymes are\u00a0distributed within sebaceous glands, keratinocytes, and sweat glands. On the other hand, Type 2 5 alpha-reductase enzymes predominately reside\u00a0in the outer root sheath of hair follicles, epididymis, vas deferens, seminal vesicles, and prostate. The average hair growth cycle consists of\u00a04 phases: Anagen (growth) Catagen (involution) Telogen (resting) Exogen (hair shedding)", "contents": "Androgenetic Alopecia -- Pathophysiology -- Important\u00a0Background Information. The Type\u00a01 isoform of 5 alpha-reductase enzymes are\u00a0distributed within sebaceous glands, keratinocytes, and sweat glands. On the other hand, Type 2 5 alpha-reductase enzymes predominately reside\u00a0in the outer root sheath of hair follicles, epididymis, vas deferens, seminal vesicles, and prostate. The average hair growth cycle consists of\u00a04 phases: Anagen (growth) Catagen (involution) Telogen (resting) Exogen (hair shedding)"}
{"id": "article-17526_10", "title": "Androgenetic Alopecia -- Pathophysiology -- Important\u00a0Background Information", "content": "Approximately\u00a080%\u00a0to\u00a090%\u00a0of the hair is in the anagen phase, which spans\u00a0from\u00a02 to\u00a06 years, ultimately determining hair length. Less than\u00a05%\u00a0of the hair is in the catagen phase,\u00a0while the rest are in the telogen phase. The natural exogen phase entails the shedding of around 100 hairs per day.", "contents": "Androgenetic Alopecia -- Pathophysiology -- Important\u00a0Background Information. Approximately\u00a080%\u00a0to\u00a090%\u00a0of the hair is in the anagen phase, which spans\u00a0from\u00a02 to\u00a06 years, ultimately determining hair length. Less than\u00a05%\u00a0of the hair is in the catagen phase,\u00a0while the rest are in the telogen phase. The natural exogen phase entails the shedding of around 100 hairs per day."}
{"id": "article-17526_11", "title": "Androgenetic Alopecia -- History and Physical", "content": "Androgenetic alopecia\u00a0manifests as a gradual and predictable hair loss pattern after puberty. In men, it\u00a0typically begins with\u00a0bitemporal thinning of the frontal scalp followed by\u00a0involvement of\u00a0the vertex (see Image. Male-Pattern Androgenetic Alopecia). In women,\u00a0the hair thinning is more diffuse, often concentrated on the crown of the scalp while retaining the frontal hairline.", "contents": "Androgenetic Alopecia -- History and Physical. Androgenetic alopecia\u00a0manifests as a gradual and predictable hair loss pattern after puberty. In men, it\u00a0typically begins with\u00a0bitemporal thinning of the frontal scalp followed by\u00a0involvement of\u00a0the vertex (see Image. Male-Pattern Androgenetic Alopecia). In women,\u00a0the hair thinning is more diffuse, often concentrated on the crown of the scalp while retaining the frontal hairline."}
{"id": "article-17526_12", "title": "Androgenetic Alopecia -- History and Physical", "content": "The physical examination of a person with androgenetic alopecia involves assessing the pattern and extent of hair loss. The Norwood-Hamilton scale is commonly used to classify male-pattern baldness, while the Ludwig scale is used for female-pattern baldness. These scales help categorize the severity of hair loss and guide treatment decisions. [12]", "contents": "Androgenetic Alopecia -- History and Physical. The physical examination of a person with androgenetic alopecia involves assessing the pattern and extent of hair loss. The Norwood-Hamilton scale is commonly used to classify male-pattern baldness, while the Ludwig scale is used for female-pattern baldness. These scales help categorize the severity of hair loss and guide treatment decisions. [12]"}
{"id": "article-17526_13", "title": "Androgenetic Alopecia -- History and Physical", "content": "During a physical examination, a healthcare provider might also look for signs of increased hair shedding, miniaturized hair follicles, and the overall condition of the scalp. Dermoscopy, a noninvasive technique involving a unique magnifying tool, can aid in visualizing the hair follicles and diagnosing androgenetic alopecia.", "contents": "Androgenetic Alopecia -- History and Physical. During a physical examination, a healthcare provider might also look for signs of increased hair shedding, miniaturized hair follicles, and the overall condition of the scalp. Dermoscopy, a noninvasive technique involving a unique magnifying tool, can aid in visualizing the hair follicles and diagnosing androgenetic alopecia."}
{"id": "article-17526_14", "title": "Androgenetic Alopecia -- History and Physical", "content": "It's important to note that while androgenetic alopecia is the most common cause of hair loss, other factors such as medical conditions, medications, and stress can also contribute to hair thinning and loss. For example, in\u00a0women, pattern baldness is often unmasked by telogen effluvium, which occurs 1 to 6 months after a stressor causes a larger portion of the hair to shift from the anagen phase to the telogen phase, leading to an increasing number of hair\u00a0follicles in the exogen phase. Another example is that in men, early androgenetic alopecia is defined as occurring before 30 years and is seen as the male phenotypic equivalent to polycystic ovarian syndrome.", "contents": "Androgenetic Alopecia -- History and Physical. It's important to note that while androgenetic alopecia is the most common cause of hair loss, other factors such as medical conditions, medications, and stress can also contribute to hair thinning and loss. For example, in\u00a0women, pattern baldness is often unmasked by telogen effluvium, which occurs 1 to 6 months after a stressor causes a larger portion of the hair to shift from the anagen phase to the telogen phase, leading to an increasing number of hair\u00a0follicles in the exogen phase. Another example is that in men, early androgenetic alopecia is defined as occurring before 30 years and is seen as the male phenotypic equivalent to polycystic ovarian syndrome."}
{"id": "article-17526_15", "title": "Androgenetic Alopecia -- Evaluation", "content": "Androgenetic alopecia is usually diagnosed\u00a0through clinical evaluation, involving\u00a0a history of gradual onset after puberty and often, but not necessarily, a\u00a0familial history of baldness. Biopsy is usually not necessary unless the diagnosis\u00a0remains unclear. Dermoscopy\u00a0can reveal miniaturized hair and brown perihilar casts, aiding in\u00a0distinguishing it\u00a0from diffuse alopecia areata that\u00a0resembles\u00a0male pattern baldness. Diffuse alopecia areata will\u00a0exhibit tapered fractures such as exclamation point hairs. [8] [10]", "contents": "Androgenetic Alopecia -- Evaluation. Androgenetic alopecia is usually diagnosed\u00a0through clinical evaluation, involving\u00a0a history of gradual onset after puberty and often, but not necessarily, a\u00a0familial history of baldness. Biopsy is usually not necessary unless the diagnosis\u00a0remains unclear. Dermoscopy\u00a0can reveal miniaturized hair and brown perihilar casts, aiding in\u00a0distinguishing it\u00a0from diffuse alopecia areata that\u00a0resembles\u00a0male pattern baldness. Diffuse alopecia areata will\u00a0exhibit tapered fractures such as exclamation point hairs. [8] [10]"}
{"id": "article-17526_16", "title": "Androgenetic Alopecia -- Evaluation", "content": "Conducting a comprehensive review of systems, medical history, and current medication regimen is important to rule out alternative causes for hair loss\u00a0and to identify potential triggers for the manifestation of\u00a0androgenetic alopecia. Additional studies might include thyroid studies, a complete blood count, and screening for iron deficiency through assessments of serum iron levels, total iron binding capacity, and serum ferritin levels. [13] [14] If there is suspicion, screening for syphilis could also be considered. [15] Furthermore, performing a\u00a0brief psychiatric\u00a0assessment\u00a0to identify signs of\u00a0depressive symptoms and other psychiatric disorders may also be warranted for all patients seeking dermatological evaluation for hair loss. [16]", "contents": "Androgenetic Alopecia -- Evaluation. Conducting a comprehensive review of systems, medical history, and current medication regimen is important to rule out alternative causes for hair loss\u00a0and to identify potential triggers for the manifestation of\u00a0androgenetic alopecia. Additional studies might include thyroid studies, a complete blood count, and screening for iron deficiency through assessments of serum iron levels, total iron binding capacity, and serum ferritin levels. [13] [14] If there is suspicion, screening for syphilis could also be considered. [15] Furthermore, performing a\u00a0brief psychiatric\u00a0assessment\u00a0to identify signs of\u00a0depressive symptoms and other psychiatric disorders may also be warranted for all patients seeking dermatological evaluation for hair loss. [16]"}
{"id": "article-17526_17", "title": "Androgenetic Alopecia -- Treatment / Management", "content": "Two FDA-approved\u00a0treatments are available\u00a0for pattern baldness: topical minoxidil and finasteride.\u00a0These treatments\u00a0require at least\u00a04 to\u00a06 months of consistent\u00a0application before\u00a0noticeable improvements become apparent, and\u00a0they require ongoing,\u00a0indefinite usage to sustain\u00a0results. [17] Due to this perpetual requirement, maintaining consistent medication adherence can be challenging. Additionally, initiation of these medications may trigger an initial shedding phase. Notably, the combined usage of these treatments often yields\u00a0more favorable outcomes. [18] [19] [20]", "contents": "Androgenetic Alopecia -- Treatment / Management. Two FDA-approved\u00a0treatments are available\u00a0for pattern baldness: topical minoxidil and finasteride.\u00a0These treatments\u00a0require at least\u00a04 to\u00a06 months of consistent\u00a0application before\u00a0noticeable improvements become apparent, and\u00a0they require ongoing,\u00a0indefinite usage to sustain\u00a0results. [17] Due to this perpetual requirement, maintaining consistent medication adherence can be challenging. Additionally, initiation of these medications may trigger an initial shedding phase. Notably, the combined usage of these treatments often yields\u00a0more favorable outcomes. [18] [19] [20]"}
{"id": "article-17526_18", "title": "Androgenetic Alopecia -- Treatment / Management", "content": "Topical minoxidil is available over the counter (OTC) and\u00a0is offered in various strengths,\u00a0with formulations extending up\u00a0to 5% solution. Higher strengths are more effective. The most common adverse effects\u00a0are pruritus and local irritation, leading to flaking. [21] The\u00a0flaking issue\u00a0is usually due to propylene glycol or alcohol\u00a0within the drug's formulation. Minoxidil\u00a0functions as a potassium channel blocker, facilitating the dilation of blood vessels. This theoretical enhancement of vascular access is postulated to enable heightened oxygen, blood,\u00a0and nutrient delivery to hair follicles, stimulating the anagen growth phase.", "contents": "Androgenetic Alopecia -- Treatment / Management. Topical minoxidil is available over the counter (OTC) and\u00a0is offered in various strengths,\u00a0with formulations extending up\u00a0to 5% solution. Higher strengths are more effective. The most common adverse effects\u00a0are pruritus and local irritation, leading to flaking. [21] The\u00a0flaking issue\u00a0is usually due to propylene glycol or alcohol\u00a0within the drug's formulation. Minoxidil\u00a0functions as a potassium channel blocker, facilitating the dilation of blood vessels. This theoretical enhancement of vascular access is postulated to enable heightened oxygen, blood,\u00a0and nutrient delivery to hair follicles, stimulating the anagen growth phase."}
{"id": "article-17526_19", "title": "Androgenetic Alopecia -- Treatment / Management", "content": "Finasteride is a 5 alpha-reductase type 2 inhibitor rather than functioning as an antiandrogen agent. [22] Typically\u00a0prescribed at a daily dose of 1 mg, it displays greater effectiveness\u00a0in\u00a0promoting hair regrowth at the vertex region of the scalp compared to the frontal area. The efficacy of finasteride in addressing female pattern baldness remains uncertain, and it is contraindicated for women\u00a0of reproductive potential (Category X)\u00a0due to the risk of inducing ambiguous genitalia development in male fetuses. [23] Potential adverse effects include sexual dysfunction, which usually improves with time, an increased risk of high-grade prostate cancer\u00a0due to masking of PSA levels and delayed detection, and case reports of persistent diminished libido with or without erectile dysfunction. [24] [25]", "contents": "Androgenetic Alopecia -- Treatment / Management. Finasteride is a 5 alpha-reductase type 2 inhibitor rather than functioning as an antiandrogen agent. [22] Typically\u00a0prescribed at a daily dose of 1 mg, it displays greater effectiveness\u00a0in\u00a0promoting hair regrowth at the vertex region of the scalp compared to the frontal area. The efficacy of finasteride in addressing female pattern baldness remains uncertain, and it is contraindicated for women\u00a0of reproductive potential (Category X)\u00a0due to the risk of inducing ambiguous genitalia development in male fetuses. [23] Potential adverse effects include sexual dysfunction, which usually improves with time, an increased risk of high-grade prostate cancer\u00a0due to masking of PSA levels and delayed detection, and case reports of persistent diminished libido with or without erectile dysfunction. [24] [25]"}
{"id": "article-17526_20", "title": "Androgenetic Alopecia -- Treatment / Management", "content": "Other drugs used in the management of pattern baldness lack FDA approval. Dutasteride, in particular, is noteworthy as it is approximately 3 times more potent against type II 5 alpha-reductase enzyme and 100 times more potent\u00a0against the type 1 enzyme. It is often used for patients who\u00a0have not experienced satisfactory results with\u00a0finasteride. [26] The adverse effect\u00a0profile of dutasteride\u00a0is similar to that of finasteride. [27]", "contents": "Androgenetic Alopecia -- Treatment / Management. Other drugs used in the management of pattern baldness lack FDA approval. Dutasteride, in particular, is noteworthy as it is approximately 3 times more potent against type II 5 alpha-reductase enzyme and 100 times more potent\u00a0against the type 1 enzyme. It is often used for patients who\u00a0have not experienced satisfactory results with\u00a0finasteride. [26] The adverse effect\u00a0profile of dutasteride\u00a0is similar to that of finasteride. [27]"}
{"id": "article-17526_21", "title": "Androgenetic Alopecia -- Treatment / Management", "content": "In women, oral antiandrogens like spironolactone are often used to treat pattern baldness. Spironolactone\u00a0exhibits\u00a0a very weak partial agonist\u00a0toward the androgen receptor.\u00a0Its primary mode of action involves\u00a0blocking the more potent DHT and free testosterone from\u00a0binding to the\u00a0androgen receptor, physiologically behaving like a direct antagonist.\u00a0Additionally, spironolactone inhibits androgen synthesis and enhances the conversion of testosterone to estradiol.", "contents": "Androgenetic Alopecia -- Treatment / Management. In women, oral antiandrogens like spironolactone are often used to treat pattern baldness. Spironolactone\u00a0exhibits\u00a0a very weak partial agonist\u00a0toward the androgen receptor.\u00a0Its primary mode of action involves\u00a0blocking the more potent DHT and free testosterone from\u00a0binding to the\u00a0androgen receptor, physiologically behaving like a direct antagonist.\u00a0Additionally, spironolactone inhibits androgen synthesis and enhances the conversion of testosterone to estradiol."}
{"id": "article-17526_22", "title": "Androgenetic Alopecia -- Treatment / Management", "content": "Although there haven't\u00a0been\u00a0documented cases\u00a0of serious adverse effects associated with spironolactone use, there are some noteworthy side effects. Oral spironolactone's most commonly reported side effects include menstrual irregularities, dizziness or headache, facial hypertrichosis, rash, and hyperkalemia. [28] [29] Research suggests that these side effects are usually self-resolving and manageable, with less than 5% of patients discontinuing spironolactone\u00a0due to these reasons. [29]", "contents": "Androgenetic Alopecia -- Treatment / Management. Although there haven't\u00a0been\u00a0documented cases\u00a0of serious adverse effects associated with spironolactone use, there are some noteworthy side effects. Oral spironolactone's most commonly reported side effects include menstrual irregularities, dizziness or headache, facial hypertrichosis, rash, and hyperkalemia. [28] [29] Research suggests that these side effects are usually self-resolving and manageable, with less than 5% of patients discontinuing spironolactone\u00a0due to these reasons. [29]"}
{"id": "article-17526_23", "title": "Androgenetic Alopecia -- Treatment / Management", "content": "In contrast, men using spironolactone\u00a0may\u00a0experience side effects like gynecomastia, decreased libido, and mild impotence. [30] These potential side effects should be discussed with a healthcare\u00a0professional when considering spironolactone therapy for pattern baldness in either gender.", "contents": "Androgenetic Alopecia -- Treatment / Management. In contrast, men using spironolactone\u00a0may\u00a0experience side effects like gynecomastia, decreased libido, and mild impotence. [30] These potential side effects should be discussed with a healthcare\u00a0professional when considering spironolactone therapy for pattern baldness in either gender."}
{"id": "article-17526_24", "title": "Androgenetic Alopecia -- Treatment / Management", "content": "A similar drug, Cyproterone acetate, is used for similar purposes internationally but is not accessible in the United States. [31] Antiandrogens tend to be more effective\u00a0when\u00a0other signs of virilization are present, which can make them a less favorable choice to treat alopecia solely. [32]", "contents": "Androgenetic Alopecia -- Treatment / Management. A similar drug, Cyproterone acetate, is used for similar purposes internationally but is not accessible in the United States. [31] Antiandrogens tend to be more effective\u00a0when\u00a0other signs of virilization are present, which can make them a less favorable choice to treat alopecia solely. [32]"}
{"id": "article-17526_25", "title": "Androgenetic Alopecia -- Treatment / Management", "content": "Red light or laser at 660 nm has effectively addressed\u00a0hair loss and is available OTC for managing pattern baldness. Low-level laser therapy has emerged as a\u00a0superior nonsurgical treatment option for androgenetic alopecia. [33]", "contents": "Androgenetic Alopecia -- Treatment / Management. Red light or laser at 660 nm has effectively addressed\u00a0hair loss and is available OTC for managing pattern baldness. Low-level laser therapy has emerged as a\u00a0superior nonsurgical treatment option for androgenetic alopecia. [33]"}
{"id": "article-17526_26", "title": "Androgenetic Alopecia -- Treatment / Management", "content": "Hair transplantation can be effective and cosmetically satisfactory\u00a0for\u00a0specific patients. [34] However, patients must\u00a0possess\u00a0an adequate volume of donor hair, typically greater than 40 follicular units/cm\u00b2) to adequately cover the bald area.\u00a0Advances in\u00a0techniques have significantly\u00a0improved the cosmetic outcomes of\u00a0hair transplantation, resulting in more natural and pleasing results.", "contents": "Androgenetic Alopecia -- Treatment / Management. Hair transplantation can be effective and cosmetically satisfactory\u00a0for\u00a0specific patients. [34] However, patients must\u00a0possess\u00a0an adequate volume of donor hair, typically greater than 40 follicular units/cm\u00b2) to adequately cover the bald area.\u00a0Advances in\u00a0techniques have significantly\u00a0improved the cosmetic outcomes of\u00a0hair transplantation, resulting in more natural and pleasing results."}
{"id": "article-17526_27", "title": "Androgenetic Alopecia -- Treatment / Management", "content": "Other proposed treatments for androgenetic alopecia include saw palmetto extract (Serenoa Repens), prostaglandin analogs like latanoprost and bimatoprost (which may be cost-prohibitive), and multiple growth factors. Platelet-rich plasma and adipose-derived stem cells are also considered in some cases, theoretically, for their potential to enhance hair growth. It is important to note that these treatments are typically not used as standalone modalities but as adjunctive therapies in combination with other established treatments for androgenetic alopecia.", "contents": "Androgenetic Alopecia -- Treatment / Management. Other proposed treatments for androgenetic alopecia include saw palmetto extract (Serenoa Repens), prostaglandin analogs like latanoprost and bimatoprost (which may be cost-prohibitive), and multiple growth factors. Platelet-rich plasma and adipose-derived stem cells are also considered in some cases, theoretically, for their potential to enhance hair growth. It is important to note that these treatments are typically not used as standalone modalities but as adjunctive therapies in combination with other established treatments for androgenetic alopecia."}
{"id": "article-17526_28", "title": "Androgenetic Alopecia -- Differential Diagnosis", "content": "Differential diagnoses of androgenetic alopecia\u00a0encompass other hair loss disorders such as: Alopecia areata Anagen effluvium Syphilis Systemic diseases Telogen effluvium", "contents": "Androgenetic Alopecia -- Differential Diagnosis. Differential diagnoses of androgenetic alopecia\u00a0encompass other hair loss disorders such as: Alopecia areata Anagen effluvium Syphilis Systemic diseases Telogen effluvium"}
{"id": "article-17526_29", "title": "Androgenetic Alopecia -- Prognosis", "content": "Androgenetic alopecia, as a standalone condition, is not considered life-threatening and does not directly result in mortality. However, in some instances,\u00a0this condition\u00a0can be\u00a0associated\u00a0with other underlying severe pathologies that\u00a0may coexist in a patient and potentially contribute to adverse health outcomes.", "contents": "Androgenetic Alopecia -- Prognosis. Androgenetic alopecia, as a standalone condition, is not considered life-threatening and does not directly result in mortality. However, in some instances,\u00a0this condition\u00a0can be\u00a0associated\u00a0with other underlying severe pathologies that\u00a0may coexist in a patient and potentially contribute to adverse health outcomes."}
{"id": "article-17526_30", "title": "Androgenetic Alopecia -- Prognosis", "content": "Several factors, including early onset, gender, surface area involvement, family history, treatment choices, compliance with treatment, and lifestyle factors, can influence the prognosis of androgenetic alopecia. [35] The prognosis for androgenetic alopecia is highly individualized, with outcomes varying from person to person.\u00a0Although androgenetic alopecia is a chronic and progressive condition, early intervention and appropriate management strategies can help decrease hair loss over time,\u00a0potentially leading to improved outcomes for the patient.", "contents": "Androgenetic Alopecia -- Prognosis. Several factors, including early onset, gender, surface area involvement, family history, treatment choices, compliance with treatment, and lifestyle factors, can influence the prognosis of androgenetic alopecia. [35] The prognosis for androgenetic alopecia is highly individualized, with outcomes varying from person to person.\u00a0Although androgenetic alopecia is a chronic and progressive condition, early intervention and appropriate management strategies can help decrease hair loss over time,\u00a0potentially leading to improved outcomes for the patient."}
{"id": "article-17526_31", "title": "Androgenetic Alopecia -- Complications", "content": "While some\u00a0men may experience rapid progress to complete baldness within a few years, others may\u00a0present with a\u00a0patterned thinning of the scalp. In contrast, women often encounter hair loss at the crown of the head and rarely develop complete baldness. Once hair is lost, the scalp becomes exposed to the sun's UV rays, and evidence suggests\u00a0that this\u00a0exposure may heighten\u00a0the risk of developing actinic keratosis. [36]", "contents": "Androgenetic Alopecia -- Complications. While some\u00a0men may experience rapid progress to complete baldness within a few years, others may\u00a0present with a\u00a0patterned thinning of the scalp. In contrast, women often encounter hair loss at the crown of the head and rarely develop complete baldness. Once hair is lost, the scalp becomes exposed to the sun's UV rays, and evidence suggests\u00a0that this\u00a0exposure may heighten\u00a0the risk of developing actinic keratosis. [36]"}
{"id": "article-17526_32", "title": "Androgenetic Alopecia -- Complications", "content": "Extensive research\u00a0has consistently\u00a0demonstrated a strong relationship between pattern baldness,\u00a0especially when it manifests early or involves vertex hair loss, and cardiovascular diseases, especially in males. These cardiovascular conditions include hypertension, myocardial infarction, insulin resistance,\u00a0mortality resulting\u00a0from diabetes or heart diseases, abnormal lipid profiles, obesity, and infertility. [37] [38] In females, androgenetic alopecia has been linked to conditions like polycystic ovarian disease. This highlights the need for comprehensive health assessments in these cases as well.", "contents": "Androgenetic Alopecia -- Complications. Extensive research\u00a0has consistently\u00a0demonstrated a strong relationship between pattern baldness,\u00a0especially when it manifests early or involves vertex hair loss, and cardiovascular diseases, especially in males. These cardiovascular conditions include hypertension, myocardial infarction, insulin resistance,\u00a0mortality resulting\u00a0from diabetes or heart diseases, abnormal lipid profiles, obesity, and infertility. [37] [38] In females, androgenetic alopecia has been linked to conditions like polycystic ovarian disease. This highlights the need for comprehensive health assessments in these cases as well."}
{"id": "article-17526_33", "title": "Androgenetic Alopecia -- Complications", "content": "The data on the connection between androgenetic alopecia\u00a0and\u00a0benign prostate hypertrophy is inconclusive, with mixed findings. However, evidence suggests\u00a0a 2-fold\u00a0increased risk of prostate cancer and a higher incidence of\u00a0mortality associated with prostate cancer in individuals with androgenetic alopecia. [39] Additionally, there\u00a0is a modestly\u00a0elevated\u00a0risk of colon cancer and urolithiasis\u00a0among patients with androgenetic alopecia. [40] [41]", "contents": "Androgenetic Alopecia -- Complications. The data on the connection between androgenetic alopecia\u00a0and\u00a0benign prostate hypertrophy is inconclusive, with mixed findings. However, evidence suggests\u00a0a 2-fold\u00a0increased risk of prostate cancer and a higher incidence of\u00a0mortality associated with prostate cancer in individuals with androgenetic alopecia. [39] Additionally, there\u00a0is a modestly\u00a0elevated\u00a0risk of colon cancer and urolithiasis\u00a0among patients with androgenetic alopecia. [40] [41]"}
{"id": "article-17526_34", "title": "Androgenetic Alopecia -- Enhancing Healthcare Team Outcomes", "content": "Androgenetic alopecia is a prevalent condition that can significantly impact the appearance and self-esteem of both males and females.\u00a0Alopecia is a\u00a0common issue encountered in\u00a0dermatology clinics, yet many patients feel embarrassed to seek medical\u00a0assistance, often resorting to online solutions. Essential to addressing this disorder is patient education.", "contents": "Androgenetic Alopecia -- Enhancing Healthcare Team Outcomes. Androgenetic alopecia is a prevalent condition that can significantly impact the appearance and self-esteem of both males and females.\u00a0Alopecia is a\u00a0common issue encountered in\u00a0dermatology clinics, yet many patients feel embarrassed to seek medical\u00a0assistance, often resorting to online solutions. Essential to addressing this disorder is patient education."}
{"id": "article-17526_35", "title": "Androgenetic Alopecia -- Enhancing Healthcare Team Outcomes", "content": "Treating androgenetic alopecia often involves an interprofessional team of healthcare practitioners working together to provide comprehensive care. An interprofessional team can collaborate to treat androgenetic alopecia in the following ways: Dermatologist: The primary healthcare provider responsible for diagnosing and managing androgenetic alopecia. They can perform a thorough evaluation, recommend appropriate treatments, and monitor the condition's progress. Primary care physician: PCPs, including physicians and advanced practitioners, can be critical in identifying risk factors for androgenetic alopecia during routine check-ups. They may refer patients to dermatologists for specialized care and coordinate overall healthcare.", "contents": "Androgenetic Alopecia -- Enhancing Healthcare Team Outcomes. Treating androgenetic alopecia often involves an interprofessional team of healthcare practitioners working together to provide comprehensive care. An interprofessional team can collaborate to treat androgenetic alopecia in the following ways: Dermatologist: The primary healthcare provider responsible for diagnosing and managing androgenetic alopecia. They can perform a thorough evaluation, recommend appropriate treatments, and monitor the condition's progress. Primary care physician: PCPs, including physicians and advanced practitioners, can be critical in identifying risk factors for androgenetic alopecia during routine check-ups. They may refer patients to dermatologists for specialized care and coordinate overall healthcare."}
{"id": "article-17526_36", "title": "Androgenetic Alopecia -- Enhancing Healthcare Team Outcomes", "content": "Pharmacist: The pharmacist is valuable in educating patients about medications used to treat androgenetic alopecia, such as minoxidil and finasteride. They can provide information on proper usage, potential side effects, and drug interactions, ensuring patients adhere to their treatment plans. Endocrinologist: In cases where hormonal imbalances are suspected, an endocrinologist may be consulted to assess and manage hormonal issues contributing to androgenetic alopecia. Plastic surgeon: Patients may consider hair transplant surgery in advanced cases of androgenetic alopecia where medical treatments have not yielded satisfactory results. Plastic surgeons can perform these procedures. Nutritionist/Dietitian :\u00a0Dietary factors can influence hair health. Nutritionists or dietitians can guide dietary changes and nutritional supplements that may promote hair growth and overall hair health.", "contents": "Androgenetic Alopecia -- Enhancing Healthcare Team Outcomes. Pharmacist: The pharmacist is valuable in educating patients about medications used to treat androgenetic alopecia, such as minoxidil and finasteride. They can provide information on proper usage, potential side effects, and drug interactions, ensuring patients adhere to their treatment plans. Endocrinologist: In cases where hormonal imbalances are suspected, an endocrinologist may be consulted to assess and manage hormonal issues contributing to androgenetic alopecia. Plastic surgeon: Patients may consider hair transplant surgery in advanced cases of androgenetic alopecia where medical treatments have not yielded satisfactory results. Plastic surgeons can perform these procedures. Nutritionist/Dietitian :\u00a0Dietary factors can influence hair health. Nutritionists or dietitians can guide dietary changes and nutritional supplements that may promote hair growth and overall hair health."}
{"id": "article-17526_37", "title": "Androgenetic Alopecia -- Enhancing Healthcare Team Outcomes", "content": "Psychologist: Hair loss can have a significant psychological impact on individuals. Psychologists or counselors can help patients cope with the emotional and psychological effects of hair loss, offering strategies to improve self-esteem and body image.", "contents": "Androgenetic Alopecia -- Enhancing Healthcare Team Outcomes. Psychologist: Hair loss can have a significant psychological impact on individuals. Psychologists or counselors can help patients cope with the emotional and psychological effects of hair loss, offering strategies to improve self-esteem and body image."}
{"id": "article-17526_38", "title": "Androgenetic Alopecia -- Enhancing Healthcare Team Outcomes", "content": "Despite the availability\u00a0of various medications and hair transplant procedures, the outcomes of treatments for androgenetic alopecia remain\u00a0unpredictable. Providing simple\u00a0reassurance that this is a benign disorder may suffice for patients not significantly distressed by hair thinning. Clinicians and pharmacists must collaborate\u00a0in educating patients about this emotionally challenging issue, ensuring they are well-informed about available options, potential risks, and expected outcomes. [4] [42] [43]", "contents": "Androgenetic Alopecia -- Enhancing Healthcare Team Outcomes. Despite the availability\u00a0of various medications and hair transplant procedures, the outcomes of treatments for androgenetic alopecia remain\u00a0unpredictable. Providing simple\u00a0reassurance that this is a benign disorder may suffice for patients not significantly distressed by hair thinning. Clinicians and pharmacists must collaborate\u00a0in educating patients about this emotionally challenging issue, ensuring they are well-informed about available options, potential risks, and expected outcomes. [4] [42] [43]"}
{"id": "article-17526_39", "title": "Androgenetic Alopecia -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Androgenetic Alopecia -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}